EW
Edwards Lifesciences Corporation (EW)
Last Price$71.4(0.3%)
Market Cap$43.4B
Last Earnings date
Sep'24
Q3 2024
$5.14
673.4% beat
$1,354.4M
12.3% miss
Next quarter EPS Estimate
$0.55
(14.1%)YoY

EW Earnings and Expectations

Revenue

Crunching data... Almost there!

EW EPS (Earnings Per Share)

Crunching data... Almost there!

EW Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$500.0M$1,000.0M$1,500.0MJan'20Apr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24$1,174.1M$925.0M$1,191.7M$1,376.0M$1,329.7M$1,373.9M$1,348.3M$1,530.2M$1,534.1M$1,385.9M
Value Sense
Actual Revenue
Forecast Revenue

EW Earnings History

Dec'14Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24
Revenue actual$618.0M$590.3M$616.8M$615.5M$671.1M$697.3M$759.3M$739.4M$767.7M$883.5M$841.8M$821.5M$888.5M$894.8M$943.7M$906.6M$977.7M$993.0M$1,086.9M$1,094.0M$1,174.1M$1,128.7M$925.0M$1,140.9M$1,191.7M$1,216.6M$1,376.0M$1,310.2M$1,329.7M$1,341.2M$1,373.9M$1,319.0M$1,348.3M$1,459.6M$1,530.2M$1,480.9M$1,534.1M$1,598.2M$1,385.9M$1,354.4M
Revenue estimate$481.2M$548.1M$548.1M$548.1M$548.1M$648.2M$648.2M$648.2M$648.2M$770.7M$770.7M$770.7M$770.7M$814.1M$814.1M$814.1M$814.1M$989.3M$1,045.2M$1,036.5M$1,144.9M$1,083.6M$793.9M$1,080.5M$1,184.5M$1,162.2M$1,282.8M$1,322.0M$1,353.0M$1,310.2M$1,396.2M$1,333.9M$1,333.7M$1,394.5M$1,505.2M$1,480.0M$1,496.8M$1,570.0M$1,653.3M$1,544.4M
Revenue surprise28.4%7.7%12.5%12.3%22.4%7.6%17.1%14.1%18.4%14.6%9.2%6.6%15.3%9.9%15.9%11.4%20.1%0.4%4.0%5.5%2.5%4.2%16.5%5.6%0.6%4.7%7.3%0.9%1.7%2.4%1.6%1.1%1.1%4.7%1.7%0.1%2.5%1.8%16.2%12.3%
EPS actual$0.17$0.19$0.18$0.18$0.22$0.22$0.20$0.22$0.25$0.36$0.29$0.27$0.06$0.33$0.45$0.36$0.01$0.40$0.39$0.44$0.45$0.50($0.20)$0.52$0.50$0.54$0.79$0.55$0.54$0.60$0.65$0.55$0.65$0.56$0.51$0.63$0.61$0.58$0.61$5.14
EPS estimate$0.32$0.48$0.48$0.48$0.48$0.61$0.61$0.61$0.61$0.70$0.70$0.70$0.70$1.00$1.00$1.00$1.00$0.41$0.44$0.41$0.50$0.44$0.19$0.44$0.53$0.47$0.55$0.53$0.55$0.57$0.64$0.62$0.62$0.61$0.65$0.59$0.64$0.64$0.69$0.66
EPS surprise46.9%60.4%62.5%62.5%54.2%63.9%67.2%63.9%59.0%48.6%58.6%61.4%91.9%67.0%55.0%64.0%99.0%1.9%12.0%8.2%9.1%14.0%207.1%17.4%5.7%14.2%42.4%3.3%1.5%5.0%1.5%11.5%5.5%8.0%21.3%6.2%4.3%9.8%12.1%673.4%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$1,354.4M (8.5%) YoY
$1,091.5M (3.4%) YoY
80.6% margin
Cost of revenue
$262.9M (25.0%) YoY
Operating income
$394.3M (5.8%) YoY
29.1% margin
Other: $15.8M
Net interest: $24.3M
Operating expenses
$698.5M (1.6%) YoY
Pre-tax income
$402.8M (8.3%) YoY
29.7% margin
Net income
$3,070.8M 697.8% YoY
226.7% margin
R&D
$253.4M (6.3%) YoY
18.7% of revenue
SG&A
$421.4M (4.1%) YoY
31.1% of revenue

Competing with EW Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$43.4B
$5,872.6M
$6.94
(8.5%)
715.9%
Miss by 18.1%
Beat by 640.4%
0.3%
(89.3%)
Beats: 6
Misses: 4
7.1%
(65.0%)
$242.4B
$42.0B
$7.74
7.2%
479.3%
Miss by 0.5%
Beat by 299.2%
(2.9%)
(79.2%)
Beats: 8
Misses: 2
7.3%
(33.4%)
$154.5B
$16.7B
$0.88
22.4%
(100.0%)
Beat by 3.2%
Miss by 100.0%
(2.3%)
0.0%
Beats: 8
Misses: 2
12.2%
122.5%
$150.5B
$22.6B
$7.86
10.7%
(52.5%)
Beat by 1.2%
Miss by 63.1%
(11.5%)
99.0%
Beats: 8
Misses: 2
8.0%
71.8%
$120.9B
$33.2B
$0.49
2.5%
N/A
undefinedN/A
undefinedN/A
0.4%
(175.5%)
Beats: 9
Misses: 1
3.7%
96.8%
$34.9B
$4,033.0M
$1.47
7.6%
(43.3%)
Beat by 1.2%
Miss by 25.4%
(7.4%)
0.3%
Beats: 8
Misses: 2
14.3%
42.2%
$24.7B
€18.0B
(€0.79)
(0.4%)
N/A
Miss by 14.5%
Miss by 168.2%
(3.2%)
(215.9%)
Beats: 2
Misses: 6
10.0%
(246.6%)
$21.9B
$5,398.4M
$4.74
(1.8%)
23.9%
Miss by 0.8%
Miss by 24.2%
9.1%
48.9%
Beats: 6
Misses: 4
7.0%
138.5%
$21.6B
$5,655.4M
$3.25
(100.0%)
(100.0%)
Miss by 100.0%
Miss by 100.0%
0.0%
0.0%
Beats:
Misses:
3.7%
62.6%
$19.4B
$1,900.3M
$6.05
17.2%
(2.7%)
Beat by 2.6%
Beat by 43.5%
(9.0%)
(46.5%)
Beats: 9
Misses: 1
21.2%
8.4%

FAQ

1. When was Edwards Lifesciences Corporation's last earnings date?

Edwards Lifesciences Corporation's last earnings date was Sep'24 (Q3 2024).

2. What is Edwards Lifesciences Corporation's EPS, and was there a surprise?

4. What is Edwards Lifesciences Corporation's next quarter EPS estimate?

Edwards Lifesciences Corporation's next quarter EPS estimate is $0.55, with an expected (14.1%) YoY growth.